Literature DB >> 19273134

Biochemical properties of plasminogen activator inhibitor-1.

Daniel Miotto Dupont1, Jeppe Buur Madsen, Thomas Kristensen, Julie Stove Bodker, Grant Ellsworth Blouse, Troels Wind, Peter Andre Andreasen.   

Abstract

PAI-1 is a Mr ~50,000 glycoprotein, which is the primary physiological inhibitor of the two plasminogen activators uPA and tPA. PAI-1 belongs to the serpin protein family. Studies of PAI-1 have contributed significantly to the elucidation of the protease inhibitory mechanism of serpins, which is based on a metastable native state becoming stabilised by insertion of the RCL into the central beta-sheet A and formation of covalent complexes with target proteases. In PAI-1, this insertion can occur in the absence of the protease, resulting in generation of a so-called latent, inactive form of the protein. PAI-1, in its active state, also binds to the extracellular protein vitronectin. When in complex with its target proteases, it binds with high affinity to endocytosis receptors of the low density receptor family.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19273134     DOI: 10.2741/3312

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  42 in total

1.  Targeting the autolysis loop of urokinase-type plasminogen activator with conformation-specific monoclonal antibodies.

Authors:  Kenneth A Botkjaer; Sarah Fogh; Erin C Bekes; Zhuo Chen; Grant E Blouse; Janni M Jensen; Kim K Mortensen; Mingdong Huang; Elena Deryugina; James P Quigley; Paul J Declerck; Peter A Andreasen
Journal:  Biochem J       Date:  2011-08-15       Impact factor: 3.857

Review 2.  Plasminogen activator inhibitor-1 and thrombotic cerebrovascular diseases.

Authors:  Anna Tjärnlund-Wolf; Helen Brogren; Eng H Lo; Xiaoying Wang
Journal:  Stroke       Date:  2012-08-09       Impact factor: 7.914

3.  Urokinase-type plasminogen activator-like proteases in teleosts lack genuine receptor-binding epidermal growth factor-like domains.

Authors:  René Bager; Thomas K Kristensen; Jan K Jensen; Agnieszka Szczur; Anni Christensen; Lisbeth M Andersen; Jesper S Johansen; Niels Larsen; Erik Baatrup; Mingdong Huang; Michael Ploug; Peter A Andreasen
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

4.  Involvement of miR-30c and miR-301a in immediate induction of plasminogen activator inhibitor-1 by placental growth factor in human pulmonary endothelial cells.

Authors:  Nitin Patel; Stanley M Tahara; Punam Malik; Vijay K Kalra
Journal:  Biochem J       Date:  2011-03-15       Impact factor: 3.857

5.  Biochemical and structural analyses suggest that plasminogen activators coevolved with their cognate protein substrates and inhibitors.

Authors:  Agnieszka Jendroszek; Jeppe B Madsen; Andrés Chana-Muñoz; Daniel M Dupont; Anni Christensen; Frank Panitz; Ernst-Martin Füchtbauer; Simon C Lovell; Jan K Jensen
Journal:  J Biol Chem       Date:  2019-01-16       Impact factor: 5.157

6.  Regulation of plasminogen activator inhibitor-1 expression in endothelial cells with exposure to metal nanoparticles.

Authors:  Min Yu; Yiqun Mo; Rong Wan; Sufan Chien; Xing Zhang; Qunwei Zhang
Journal:  Toxicol Lett       Date:  2010-02-18       Impact factor: 4.372

7.  Skin infections are eliminated by cooperation of the fibrinolytic and innate immune systems.

Authors:  William Santus; Simona Barresi; Francesca Mingozzi; Achille Broggi; Ivan Orlandi; Giulia Stamerra; Marina Vai; Alessandra M Martorana; Alessandra Polissi; Julia R Köhler; Ningning Liu; Ivan Zanoni; Francesca Granucci
Journal:  Sci Immunol       Date:  2017-09-22

8.  Characterization of a small molecule inhibitor of plasminogen activator inhibitor type 1 that accelerates the transition into the latent conformation.

Authors:  Ola Fjellström; Johanna Deinum; Tove Sjögren; Carina Johansson; Stefan Geschwindner; Viveca Nerme; Anne Legnehed; Jane McPheat; Karolina Olsson; Cristian Bodin; Amalia Paunovic; David Gustafsson
Journal:  J Biol Chem       Date:  2012-11-15       Impact factor: 5.157

9.  Crystal Structure of the Michaelis Complex between Tissue-type Plasminogen Activator and Plasminogen Activators Inhibitor-1.

Authors:  Lihu Gong; Min Liu; Tu Zeng; Xiaoli Shi; Cai Yuan; Peter A Andreasen; Mingdong Huang
Journal:  J Biol Chem       Date:  2015-08-31       Impact factor: 5.157

10.  Protumorigenic activity of plasminogen activator inhibitor-1 through an antiapoptotic function.

Authors:  Hua Fang; Veronica R Placencio; Yves A DeClerck
Journal:  J Natl Cancer Inst       Date:  2012-09-13       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.